Literature DB >> 17913801

Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Diana Palmeri1, Sophia Spadavecchia, Kyla Driscoll Carroll, David M Lukac.   

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV) Mta protein, encoded by open reading frame 57, is a transactivator of gene expression that is essential for productive viral replication. Previous studies have suggested both transcriptional and posttranscriptional roles for Mta, but little is known regarding Mta's transcriptional function. In this study, we demonstrate that Mta cooperates with the KSHV lytic switch protein, Rta, to reactivate KSHV from latency, but Mta has little effect on reactivation when expressed alone. We demonstrate that the Mta and Rta proteins are expressed with similar but distinct kinetics during KSHV reactivation. In single-cell analyses, Mta expression coincides tightly with progression to full viral reactivation. We demonstrate with promoter reporter assays that while Rta activates transcription in all cell lines tested, Mta's ability to transactivate promoters, either alone or synergistically with Rta, is cell and promoter specific. In particular, Mta robustly transactivates the nut-1/PAN promoter independently of Rta in 293 and Akata-31 cells. Using nuclear run-on assays, we demonstrate that Mta stimulates transcriptional initiation in 293 cells. Rta and Mta physically interact in infected cell extracts, and this interaction requires the intact leucine repeat and central region of Rta in vitro. We demonstrate that Mta also binds to the nut-1/PAN promoter DNA in vitro and in infected cells. An Mta mutant with a lesion in a putative A/T hook domain is altered in DNA binding and debilitated in transactivation. We propose that one molecular mechanism of Mta-mediated transactivation is a direct effect on transcription by direct and indirect promoter association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913801      PMCID: PMC2168867          DOI: 10.1128/JVI.00732-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  110 in total

1.  Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Masahiro Fujimuro; Jianchao Zong; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  Brian S Bowser; Scott M DeWire; Blossom Damania
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Genotyping SNPs with molecular beacons.

Authors:  Salvatore A E Marras; Fred Russell Kramer; Sanjay Tyagi
Journal:  Methods Mol Biol       Date:  2003

4.  The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Authors:  Yuying Liang; Jean Chang; Stephen J Lynch; David M Lukac; Don Ganem
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

5.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism.

Authors:  Keiji Ueda; Kayo Ishikawa; Ken Nishimura; Shuhei Sakakibara; Eunju Do; Koichi Yamanishi
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Mapping of the bovine herpesvirus 1 glycoprotein C promoter region and its specific transactivation by the viral BICP27 gene product.

Authors:  F Hamel; C Simard
Journal:  Arch Virol       Date:  2003-01       Impact factor: 2.574

7.  Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression.

Authors:  Hongyu Deng; Julia T Chu; Matthew B Rettig; Otoniel Martinez-Maza; Ren Sun
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.

Authors:  Henri Gruffat; Julien Batisse; Dagmar Pich; Bernhard Neuhierl; Evelyne Manet; Wolfgang Hammerschmidt; Alain Sergeant
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).

Authors:  Hongyu Deng; Moon Jung Song; Julia T Chu; Ren Sun
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.

Authors:  Maria Caterina Sirianni; Laura Vincenzi; Simone Topino; Antonello Giovannetti; Francesca Mazzetta; Fabio Libi; Donato Scaramuzzi; Massimo Andreoni; Elena Pinter; Sara Baccarini; Giovanni Rezza; Paolo Monini; Barbara Ensoli
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

View more
  36 in total

1.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity.

Authors:  Emi Sei; Nicholas K Conrad
Journal:  Virology       Date:  2011-09-01       Impact factor: 3.616

3.  Epstein-Barr Virus Protein EB2 Stimulates Translation Initiation of mRNAs through Direct Interactions with both Poly(A)-Binding Protein and Eukaryotic Initiation Factor 4G.

Authors:  Fabrice Mure; Baptiste Panthu; Isabelle Zanella-Cléon; Frédéric Delolme; Evelyne Manet; Théophile Ohlmann; Henri Gruffat
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

4.  Rhesus monkey rhadinovirus ORF57 induces gH and gL glycoprotein expression through posttranscriptional accumulation of target mRNAs.

Authors:  Young C Shin; Ronald C Desrosiers
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

5.  Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.

Authors:  Sophia Spadavecchia; Olga Gonzalez-Lopez; Kyla Driscoll Carroll; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

6.  Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.

Authors:  H Goto; R Kariya; E Kudo; Y Okuno; K Ueda; H Katano; S Okada
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

Review 7.  New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA.

Authors:  Nicholas K Conrad
Journal:  Virus Res       Date:  2015-06-21       Impact factor: 3.303

8.  Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Authors:  Brooke B Sahin; Denish Patel; Nicholas K Conrad
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.

Authors:  Dinesh Verma; Jacob Thompson; Sankar Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.